Atlas Wealth LLC Purchases New Shares in GE HealthCare Technologies Inc. $GEHC

Atlas Wealth LLC purchased a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 64,534 shares of the company’s stock, valued at approximately $4,594,000.

Several other institutional investors and hedge funds have also modified their holdings of the business. Assetmark Inc. grew its stake in shares of GE HealthCare Technologies by 2.5% in the first quarter. Assetmark Inc. now owns 12,939 shares of the company’s stock worth $921,000 after purchasing an additional 319 shares during the last quarter. Bessemer Group Inc. raised its position in GE HealthCare Technologies by 17.8% during the 1st quarter. Bessemer Group Inc. now owns 9,727 shares of the company’s stock worth $692,000 after purchasing an additional 1,470 shares during the last quarter. Allspring Global Investments Holdings LLC raised its position in GE HealthCare Technologies by 1.4% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 20,970 shares of the company’s stock worth $1,509,000 after purchasing an additional 286 shares during the last quarter. Independent Financial Group LLC acquired a new position in GE HealthCare Technologies during the 1st quarter worth about $321,000. Finally, D.A. Davidson & CO. lifted its holdings in GE HealthCare Technologies by 2.8% during the 1st quarter. D.A. Davidson & CO. now owns 14,707 shares of the company’s stock worth $1,047,000 after buying an additional 400 shares during the period. 82.06% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have issued reports on GEHC. Wells Fargo & Company lowered their price target on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a report on Thursday, April 30th. BMO Capital Markets assumed coverage on shares of GE HealthCare Technologies in a research note on Wednesday, July 8th. They issued a “market perform” rating and a $70.00 price objective on the stock. JPMorgan Chase & Co. decreased their price objective on shares of GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating for the company in a research report on Thursday, April 30th. Wall Street Zen downgraded shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, March 21st. Finally, Royal Bank Of Canada started coverage on shares of GE HealthCare Technologies in a report on Tuesday, June 23rd. They issued an “outperform” rating and a $80.00 target price on the stock. Ten investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $76.41.

Insider Buying and Selling

In related news, Director Kevin Lobo acquired 10,000 shares of the stock in a transaction on Friday, May 22nd. The stock was purchased at an average price of $64.18 per share, for a total transaction of $641,800.00. Following the completion of the transaction, the director owned 14,363 shares of the company’s stock, valued at $921,817.34. This trade represents a 229.20% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Rodney F. Hochman bought 1,618 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The shares were acquired at an average price of $62.03 per share, with a total value of $100,364.54. Following the acquisition, the director owned 1,618 shares of the company’s stock, valued at $100,364.54. This represents a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have purchased a total of 21,847 shares of company stock worth $1,361,355 in the last 90 days. 0.36% of the stock is currently owned by company insiders.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $63.07 on Friday. GE HealthCare Technologies Inc. has a 12 month low of $58.75 and a 12 month high of $89.77. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95. The business’s 50 day simple moving average is $63.64 and its 200 day simple moving average is $71.96. The company has a market cap of $28.69 billion, a price-to-earnings ratio of 15.09, a PEG ratio of 1.79 and a beta of 0.72.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.08). The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same period last year, the firm earned $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Friday, July 24th will be issued a $0.035 dividend. The ex-dividend date is Friday, July 24th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 3.35%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.